Protara Therapeutics, Inc. (TARA) Deferred Tax Assets, Valuation Allowance USD 2012 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protara Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2012 to 2023.
  • Protara Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $52.7 M, a 35.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $52.7 M +$13.7 M +35.1% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $39 M +$11.2 M +40.3% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $27.8 M +$6.11 M +28.1% Dec 31, 2021 10-K 2023-03-08
Q4 2020 $21.7 M +$17.5 M +420% Dec 31, 2020 10-K 2022-03-09
Q4 2019 $4.18 M -$8.18 M -66.2% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $12.4 M +$5.41 M +77.8% Dec 31, 2018 10-K 2020-03-20
Q4 2017 $6.95 M -$54.1 M -88.6% Dec 31, 2017 10-K 2019-03-13
Q4 2016 $61 M +$8.8 M +16.9% Dec 31, 2016 10-K 2019-03-13
Q4 2015 $52.2 M +$9.78 M +23% Dec 31, 2015 10-K 2018-03-14
Q4 2014 $42.5 M +$3.82 M +9.88% Dec 31, 2014 10-K 2017-03-16
Q4 2013 $38.6 M +$7.29 M +23.2% Dec 31, 2013 10-K 2016-03-14
Q4 2012 $31.4 M Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.